When CM is the only BAP1-TPDS-associated malignancy present in an individual or family, the threshold for familial CM should be ≥3 cutaneous melanomas in one individual or in the family, given its high frequency in the general population in the Netherlands. This evidence concerns the gene BAP1 and cutaneous melanoma.